Clinical Trial Update: Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining cellular immune responses in adults who received Hepatitis B vaccine but did not develop serologic protection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: University of Aarhus | Conditions: Hepatitis B | Phase 4 | Status: UNKNOWN